AI Summary of Scholarly Research

This page presents an AI-generated summary of a published research paper. The original authors did not write or review this article. [See full disclosure ↓]

Prenatal acid-suppressive drugs were not linked to child neuropsychiatric risk in sibling analyses

Research area:medicine-clinical

What the study found

The study found no significant association between prenatal exposure to acid-suppressive medication and several neuropsychiatric disorders in children when siblings were compared. Small associations appeared in one analysis, but the authors say these may reflect shared familial factors.

Why the authors say this matters

The authors conclude that their findings help clarify the relationship between acid-suppressive medications used during pregnancy and later neuropsychiatric outcomes in children. They suggest that the small associations seen in some models may be due to confounding by shared familial factors.

What the researchers tested

The researchers used a retrospective cohort study of mother-child pairs from the South Korean National Health Insurance Service database, covering births from January 2010 through December 2017 and follow-up through December 2023. They compared prenatal exposure to at least one prescription for a proton pump inhibitor (a medicine that reduces stomach acid) or an H2 receptor antagonist (another acid-reducing medicine) with no such exposure, using both a propensity score-based overlap-weighted cohort and a sibling-matched cohort.

What worked and what didn't

In the overlap-weighted cohort, exposed children had slightly higher adjusted hazard ratios for attention-deficit/hyperactivity disorder, autism spectrum disorders, intellectual disability, severe neuropsychiatric disorder, and obsessive-compulsive disorder. However, in sibling-control analyses, none of these outcomes showed a significant association with prenatal exposure.

What to keep in mind

The abstract reports that the small associations in the overlap-weighted models may reflect confounding by shared familial factors. The summary does not provide additional limitations beyond this point.

Key points

  • The study included 2,777,119 mother-child pairs, with 507,845 pairs exposed to prenatal acid-suppressive medication.
  • Follow-up of offspring averaged 10.3 years.
  • Overlap-weighted analyses showed small increases in adjusted hazard ratios for all five neuropsychiatric outcomes measured.
  • Sibling-control analyses found no significant association for attention-deficit/hyperactivity disorder, autism spectrum disorders, intellectual disability, severe neuropsychiatric disorder, or obsessive-compulsive disorder.
  • The authors suggest that shared familial factors may explain the small associations seen in one analysis.

Disclosure

Research title:
Prenatal acid-suppressive drugs were not linked to child neuropsychiatric risk in sibling analyses
Authors:
Seohyun Hong, Sooji Lee, Hyunjee Kim, Hyesu Jo, Kyeongmin Lee, Yeona Jo, Tae Hyeon Kim, Jaeyu Park, Jinseok Lee, Ho Geol Woo, Hayeon Lee, Dong Keon Yon
Institutions:
Kyung Hee University, Kyung Hee University, Kyung Hee University, Kyung Hee University, Kyung Hee University, Kyung Hee University, Kyung Hee University, Kyung Hee University, Kyung Hee University, Kyung Hee University, Kyung Hee University, Kyung Hee University Medical Center, Kyung Hee University Medical Center, Kyung Hee University Medical Center, Kyung Hee University Medical Center, Kyung Hee University Medical Center, Kyung Hee University Medical Center, Kyung Hee University Medical Center, Kyung Hee University Medical Center, Kyung Hee University Medical Center, Kyung Hee University Medical Center, Kyung Hee University Medical Center
Publication date:
2026-01-07
OpenAlex record:
View
AI provenance: This post was generated by gpt-5.4-mini-2026-03-17 (OpenAI). The original authors did not write or review this post.